The Mayo Clinic recently introduced a diagnostic test that quantifies plasma ceramides in order to identify patients at risk of major adverse cardiac events. By comparing recent discoveries about these biomarker ceramides with the exhaustive body of literature surrounding cholesterol, Summers aims to highlight important advances and critically needed areas of investigation on this exciting class of bioactive lipids.

中文翻译：

---

神经酰胺能否成为新的胆固醇？

梅奥诊所最近推出了一种诊断测试，可量化血浆神经酰胺，以识别有发生重大心脏不良事件风险的患者。通过将关于这些生物标志物神经酰胺的最新发现与围绕胆固醇的详尽文献进行比较，萨默斯旨在强调这一令人兴奋的生物活性脂质类别的重要进展和迫切需要的研究领域。